Crospon Nabs FDA Clearance for Expanded Use of EndoFLIP

Irish devicemaker Crospon has gained FDA clearance, expanding indications of use for its EndoFLIP endolumenal imaging system, the company announced today.

The EndoFLIP platform can now be used in sphincter measurements in patients suffering from gastroparesis and fecal incontinence, the company says.

The technology was released in 2010. — Anisa Jibrell